We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reprogramming Stem Cells to Be Cartilage

By Biotechdaily staff writers
Posted on 24 May 2002
Working with stem cells derived from fat tissue, researchers have shown that these cells can be converted into cartilage and induced to produce collagen. More...
As cartilage has few blood vessels, nerves and lymphatic support, it has a limited capacity for repair when damaged. This makes it an especially good candidate for replacement by engineered tissue.

The research team, from Duke University (Durham NC, USA), used fat cells left over from liposuction. These were filtered to isolate a colony of cells rich in stem cells. These cells were fed growth factors and cultured in a three-dimensional configuration to simulate the way cartilage cells grow naturally. Fat cells grown in this way began to produce collagen, a main ingredient of cartilage. When these cells were implanted under the skin of mice, they continued for three months to produce collagen and other ingredients in a matrix characteristic of cartilage. These results were reported in the April 2002 issue of Biochemical and Biophysical Research Communications.

"For patients with tissue damage, we envision being able to remove a small piece of fat and then growing customized, three-dimensional pieces of tissue that would then be surgically implanted where needed,” said Dr. Farshid Guilak, director of orthopedic research at Duke.
In a related study, cells were taken from a pad of fat that lies behind the kneecap using a minimally invasive procedure that is less disruptive than liposuction. Three groups of these cells were placed in three different environments and given steroids and growth factors that would encourage the growth of cartilage, bone, and fat. After a period of weeks, the cell cultures were examined. The first group had developed collagen matrix molecules characteristic of cartilage. The second group developed calcium phosphate deposits as if they were beginning to build a structure of bone. The third group began producing fat cells.

These results suggest that it may be possible to reprogram stem cells taken from fatty tissue into a variety of other cell types.



Related Links:
Duke University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Repetitive Pipette
VWR® Stepper Pro
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.